The demand for antibodies in China is on a steep incline, reflecting a broader shift in healthcare priorities. According to , this market is poised to expand dramatically, reaching an estimated $94.0 billion by 2035, driven primarily by the increasing prevalence of chronic diseases and the rising need for effective therapeutic options. As healthcare systems modernize, patients are becoming more...